MedPath

EL-SHIN Therapy for Depressive Symptoms

Not Applicable
Not yet recruiting
Conditions
Depressive Disorder
Registration Number
NCT06995807
Lead Sponsor
Monash University Malaysia
Brief Summary

This is a research aiming to find the effectiveness of an innovative therapy, EL-SHIN THERAPY, in ameliorating depressive symptoms.

Detailed Description

This study evaluates the effectiveness of EL-SHIN® Therapy, a novel adjunctive intervention in alleviating depressive symptoms.

There are three components in this therapy:

1. Lavender Therapy

2. GRATEFULNESS® Therapy

3. Fasting with exercise and light therapy

The study includes two phases: a quantitative clinical trial and a qualitative focus group.

Assessments will use DASS-21, MHQoL, and SQS scales with the intervention delivered in English over 3-4 weeks.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Age: Above 18 yrs old
  • DASS-21 scores:

"Moderately Depressed (Score: 14-20)", "Moderately Anxious (Score: 10-14)" & "Moderately Stressed (Score: 19-25)"

  • Non-Muslim (Due to legal restriction in Malaysia for this religion)
  • English literate
  • Believers in Creationism
Exclusion Criteria
  • Muslim (legal restrictions in Malaysia for this religion).
  • Non-English literate (research will be conducted in English only).
  • Individuals with any other medical conditions or on current medication To reduce potential complications or confounding factors).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sleep Quality Scale (SQS)3 to 4 weeks

Measuring Sleep Quality of Individuals with higher score denoting more acute sleep problem

DASS-21 Scale3 to 4 weeks

Measuring severity of Depression, Anxiety and Stress Level. Higher score indicating more severity in experiencing these symptoms

Mental Health Quality of Life (MHQoL)3 to 4 weeks

Measuring quality of life of individuals. Higher score indicating better quality of life.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.